Company / Operating Margin
Phathom Pharmaceuticals, Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-91.4%
FY2025
5-year range
-24532.5% / -91.4%
FY2023-FY2025
Trend
+99.6%
vs FY2024
Sector context
#84 of 135
Health Care
What the data says
At -91.4%, Phathom Pharmaceuticals, Inc.'s operating margin ranks #84 of 135 in the Health Care sector. Improved from -24532.5% to -91.4% over the past 2 years.
Based on SEC 10-K filings.
-91.4% in FY2025.
Improved from -24532.5% to -91.4% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#84 of 135 in Health CareTop 62% of 135This company -91.4% Sector average -774.4%
▼
+88.2% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 99.6% year-over-year.
- Currently 683.1pp above the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score -6.09 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -91.4% | +99.6% |
| FY2024 | -24532.5% | +0.0% |
| FY2023 | -24532.5% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026